Exact Mass: 527.2896252
Exact Mass Matches: 527.2896252
Found 129 metabolites which its exact mass value is equals to given mass value 527.2896252
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Doramapimod
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2149 - Mitogen-Activated Protein Kinase Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor Doramapimod (BIRB 796) is an orally active, highly potent p38 MAPK inhibitor, which has an IC50 for p38α=38 nM, for p38β=65 nM, for p38γ=200 nM, and for p38δ=520 nM. Doramapimod has picomolar affinity for p38 kinase (Kd=0.1 nM). Doramapimod also inhibits B-Raf with an IC50 of 83 nM[1][2].
Doramapimod
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2149 - Mitogen-Activated Protein Kinase Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor Doramapimod (BIRB 796) is an orally active, highly potent p38 MAPK inhibitor, which has an IC50 for p38α=38 nM, for p38β=65 nM, for p38γ=200 nM, and for p38δ=520 nM. Doramapimod has picomolar affinity for p38 kinase (Kd=0.1 nM). Doramapimod also inhibits B-Raf with an IC50 of 83 nM[1][2].
Phe His Lys Pro
Phe His Pro Lys
Phe Lys His Pro
Phe Lys Pro His
Phe Pro His Lys
Phe Pro Lys His
His Phe Lys Pro
His Phe Pro Lys
His Ile Lys Met
C23H41N7O5S (527.2889736000001)
His Ile Met Lys
C23H41N7O5S (527.2889736000001)
His Lys Phe Pro
His Lys Ile Met
C23H41N7O5S (527.2889736000001)
His Lys Leu Met
C23H41N7O5S (527.2889736000001)
His Lys Met Ile
C23H41N7O5S (527.2889736000001)
His Lys Met Leu
C23H41N7O5S (527.2889736000001)
His Lys Pro Phe
His Leu Lys Met
C23H41N7O5S (527.2889736000001)
His Leu Met Lys
C23H41N7O5S (527.2889736000001)
His Met Ile Lys
C23H41N7O5S (527.2889736000001)
His Met Lys Ile
C23H41N7O5S (527.2889736000001)
His Met Lys Leu
C23H41N7O5S (527.2889736000001)
His Met Leu Lys
C23H41N7O5S (527.2889736000001)
His Pro Phe Lys
His Pro Lys Phe
Ile His Lys Met
C23H41N7O5S (527.2889736000001)
Ile His Met Lys
C23H41N7O5S (527.2889736000001)
Ile Lys His Met
C23H41N7O5S (527.2889736000001)
Ile Lys Met His
C23H41N7O5S (527.2889736000001)
Ile Met His Lys
C23H41N7O5S (527.2889736000001)
Ile Met Lys His
C23H41N7O5S (527.2889736000001)
Lys Phe His Pro
Lys Phe Pro His
Lys His Phe Pro
Lys His Ile Met
C23H41N7O5S (527.2889736000001)
Lys His Leu Met
C23H41N7O5S (527.2889736000001)
Lys His Met Ile
C23H41N7O5S (527.2889736000001)
Lys His Met Leu
C23H41N7O5S (527.2889736000001)
Lys His Pro Phe
Lys Ile His Met
C23H41N7O5S (527.2889736000001)
Lys Ile Met His
C23H41N7O5S (527.2889736000001)
Lys Leu His Met
C23H41N7O5S (527.2889736000001)
Lys Leu Met His
C23H41N7O5S (527.2889736000001)
Lys Met His Ile
C23H41N7O5S (527.2889736000001)
Lys Met His Leu
C23H41N7O5S (527.2889736000001)
Lys Met Ile His
C23H41N7O5S (527.2889736000001)
Lys Met Leu His
C23H41N7O5S (527.2889736000001)
Lys Pro Phe His
Lys Pro His Phe
Leu His Lys Met
C23H41N7O5S (527.2889736000001)
Leu His Met Lys
C23H41N7O5S (527.2889736000001)
Leu Lys His Met
C23H41N7O5S (527.2889736000001)
Leu Lys Met His
C23H41N7O5S (527.2889736000001)
Leu Met His Lys
C23H41N7O5S (527.2889736000001)
Leu Met Lys His
C23H41N7O5S (527.2889736000001)
Met His Ile Lys
C23H41N7O5S (527.2889736000001)
Met His Lys Ile
C23H41N7O5S (527.2889736000001)
Met His Lys Leu
C23H41N7O5S (527.2889736000001)
Met His Leu Lys
C23H41N7O5S (527.2889736000001)
Met Ile His Lys
C23H41N7O5S (527.2889736000001)
Met Ile Lys His
C23H41N7O5S (527.2889736000001)
Met Lys His Ile
C23H41N7O5S (527.2889736000001)
Met Lys His Leu
C23H41N7O5S (527.2889736000001)
Met Lys Ile His
C23H41N7O5S (527.2889736000001)
Met Lys Leu His
C23H41N7O5S (527.2889736000001)
Met Leu His Lys
C23H41N7O5S (527.2889736000001)
Met Leu Lys His
C23H41N7O5S (527.2889736000001)
Pro Phe His Lys
Pro Phe Lys His
Pro His Phe Lys
Pro His Lys Phe
Pro Lys Phe His
Pro Lys His Phe
Pro Gln Gln Arg
Pro Gln Arg Gln
Pro Arg Gln Gln
Gln Pro Gln Arg
Gln Pro Arg Gln
Gln Gln Pro Arg
Gln Gln Arg Pro
Gln Arg Pro Gln
Gln Arg Gln Pro
Arg Pro Gln Gln
Arg Gln Pro Gln
Arg Gln Gln Pro
Fesoterodine Fumarate
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D000089162 - Genitourinary Agents > D064804 - Urological Agents Fesoterodine Fumarate is an orally active, nonsubtype selective, competitive muscarinic receptor (mAChR) antagonist with pKi values of 8.0, 7.7, 7.4, 7.3, 7.5 for M1, M2, M3, M4, M5 receptors, respectively. Fesoterodine Fumarate is used for the overactive bladder (OAB)[1][2].
(R)-2-(3-(Diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl isobutyrate maleate
N-[(2S,4aS,12aR)-2-[2-(cyclohexylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
N-[(2S,4aR,12aS)-2-[2-(cyclohexylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]oxane-4-carboxamide
N-[(2R,4aS,12aS)-2-[2-(cyclohexylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
N-[(2R,4aS,12aR)-2-[2-(cyclohexylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]oxane-4-carboxamide
N-[(2S,4aR,12aR)-2-[2-(cyclohexylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
N-[(2S,4aS,12aS)-2-[2-(cyclohexylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]oxane-4-carboxamide
N-[(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4,4,4-trifluorobutanamide
C27H40F3N3O4 (527.2970756000001)
N-[(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4,4,4-trifluorobutanamide
C27H40F3N3O4 (527.2970756000001)
N-[(2R,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4,4,4-trifluorobutanamide
C27H40F3N3O4 (527.2970756000001)
N-[(2R,4aR,12aS)-2-[2-(cyclohexylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
N-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4,4,4-trifluorobutanamide
C27H40F3N3O4 (527.2970756000001)
N-[(2R,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4,4,4-trifluorobutanamide
C27H40F3N3O4 (527.2970756000001)
N-[(2R,4aR,12aR)-2-[2-(cyclohexylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
n-[(1e,5r)-5-{4-hydroxy-5-[(2e,4e,9e,12e)-8-hydroxy-2,5,9-trimethyltetradeca-2,4,9,12-tetraenoyl]-6-oxopyran-2-yl}hex-1-en-1-yl]methoxycarboximidic acid
n-[(1e,5r)-5-{4-hydroxy-5-[(2e,4e,8r,9z,12e)-8-hydroxy-2,5,9-trimethyltetradeca-2,4,9,12-tetraenoyl]-6-oxopyran-2-yl}hex-1-en-1-yl]methoxycarboximidic acid
aconosine; o14-(4-methoxybenzoyl),13-hydroxy
{"Ingredient_id": "HBIN014590","Ingredient_name": "aconosine; o14-(4-methoxybenzoyl),13-hydroxy","Alias": "NA","Ingredient_formula": "C30H41NO7","Ingredient_Smile": "NA","Ingredient_weight": "527.65","OB_score": "NA","CAS_id": "131653-96-8","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7183","PubChem_id": "NA","DrugBank_id": "NA"}